Changes in chromatin structure in curettage specimens identifies high-risk patients in endometrial cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 26, Issue 1, 2017, Pages 61-67

  Hveem, Tarjei S ^a,b   Njølstad, Tormund S ^c,d   Nielsen, Birgitte ^a,b   Syvertsen, Rolf Anders ^a,b   Nesheim, John Arne ^a,b   Kjæreng, Marna L ^a,b   Kildal, Wanja ^a,b   Pradhan, Manohar ^a,b   Marcickiewicz, Janusz ^e,f   Tingulstad, Solveig ^g   Staff, Anne C ^h   Haugland, Hans K ⁱ   Eraker, Runar ^b,j   Oddenes, Klaus ^k   Rokne, Jan A ^l   Tjugum, Jostein ^m   Lode, Margaret S ⁿ   Amant, Frederic ^o   Henrica, M J ^c,d   Bjørge, Line ^c,d   Albregtsen, Fritz ^a,b   Liestøl, Knut ^b   Salvesen, Helga B ^c,d   Trovik, Jone ^c,d   Danielsen, Havard E ^a,b,p   more..

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF BERGEN   (Norway)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

^f Department of Obstetrics and Gynecology   (Sweden)

^g TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^h ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

ⁱ HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^j AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^k HAUGESUND HOSPITAL   (Norway)

^l VESTFOLD HOSPITAL TRUST   (Norway)

^m Førde Hospital Trust   (Norway)

ⁿ Alesund Hospital   (Norway)

^o UNIVERSITY OF LEUVEN   (Belgium)

^p UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CHROMATIN STRUCTURE; DISEASE SPECIFIC SURVIVAL; ENDOMETRIUM BIOPSY; ENDOMETRIUM CARCINOMA; FEMALE; GROUPS BY AGE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MYOMETRIUM; NUCLEAR TEXTURE ANALYSIS; NUCLEOTYPING; PLOIDY; PRIORITY JOURNAL; PROCEDURES CONCERNING CELLS; PROSPECTIVE STUDY; ANALYSIS OF VARIANCE; CHROMATIN; CLINICAL TRIAL; DILATATION AND CURETTAGE; ENDOMETRIUM TUMOR; FACTUAL DATABASE; GENETICS; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; NORWAY; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SPECIMEN HANDLING; SURVIVAL RATE; TUMOR INVASION;

DNA; TUMOR MARKER;

ADULT; AGED; ANALYSIS OF VARIANCE; BIOMARKERS, TUMOR; CHROMATIN; DATABASES, FACTUAL; DILATATION AND CURETTAGE; DNA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NORWAY; PLOIDIES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SPECIMEN HANDLING; SURVIVAL RATE;

EID: 85009104597     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-16-0215     Document Type: Article

References (27)

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87-108.
2. Amant F, Moerman P, Neven P, Timmerman D, Van LE, Vergote I. Endometrial cancer. Lancet 2005;366:491-505.
3. Prat J. Prognostic parameters of endometrial carcinoma. Hum Pathol 2004;35:649-62.
4. Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Warlam-Rodenhuis CC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post operative radiation therapy in endometrial carcinoma. Lancet 2000;355:1404-11.
5. Salvesen HB, Haldorsen IS, Trovik J. Markers for individualised therapy in endometrial carcinoma. Lancet Oncol 2012;13:e353-61.
6. Werner HM, Salvesen HB. Current status of molecular biomarkers in endometrial cancer. Curr Oncol Rep 2014;16:403.
7. Mauland KK, Wik E, Salvesen HB. Clinical value of DNA content assessment in endometrial cancer. Cytometry B Clin Cytom 2014;86:154-63.
8. Njølstad TS, Trovik J, HveemTS, KjærengML, Kildal W, PradhanM, et al. DNA ploidy in curettage specimens identifies high-risk patients and lymph node metastasis in endometrial cancer. Br J Cancer 2015; 112:1656-64.
9. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998;396:643-9.
10. Nielsen B, Albregtsen F, Danielsen HE. Statistical nuclear texture analysis in cancer research: A review of methods and applications. Crit Rev Oncog 2008;14:89-164.
11. Nielsen B, Albregtsen F, Kildal W, Abeler VM, Kristensen GB, Danielsen HE. The prognostic value of adaptive nuclear texture features from patient gray level entropy matrices in early stage ovarian cancer. Anal Cell Pathol 2012;35:305-14.
12. Nielsen B, Hveem TS, Kildal W, Abeler VM, Kristensen GB, Albregtsen F, et al. Entropy-based adaptive nuclear texture features are independent prognostic markers in a total population of uterine sarcomas. Cytometry A 2015;87:315-25.
13. Geisler JP, Wiemann MC, Zhou Z, Miller GA, Geisler HE. Markov texture parameters as prognostic indicators in endometrial cancer. Gynecol Oncol 1996;62:174-80.
14. Bartels PH, Garcia FA, Davis J, da Silva VD, Bartels HG, Thompson D, et al. Progression curves for endometrial lesions. Anal Quant Cytol Histol 2001;23:1-8.
15. Garcia FA, Davis JR, Alberts DS, Hatch K, Weyn B, Thompson D, et al. Nuclear chromatin patterns in normal, hyperplastic and atypical endometrium. Anal Quant Cytol Histol 2001;23:144-50.
16. Garcia FA, Davis JR, Hatch K, Alberts DS, Thompson D, Bartels PH. Karyometry in endometrial adenocarcinoma of different grades. Anal Quant Cytol Histol 2002;24:93-102.
17. Bartels PH, Garcia FA, Trimble CL, Kauderer J, Curtin J, Lim PC, et al. Karyometry in atypical endometrial hyperplasia: A Gynecologic Oncology Group study. Gynecol Oncol 2012;125:129-35.
18. Diegenbach PC, Baak JP. Quantitative nuclear image analysis: differentiation between normal, hyperplastic, and malignant appearing uterine glands in a paraffin section. III. The use of texture features for differentiation. Eur J Obstet Gynecol Reprod Biol 1978;8:109-16.
19. Diegenbach PC, Baak JP. Quantitative nuclear image analysis: differentiation between normal, hyperplastic, and malignant appearing uterine glands in a paraffin section. IV. The use of Markov chain texture features in discriminant analysis. Eur J Obstet Gynecol Reprod Biol 1978;8:157-62.
20. Baak JP, Kurver PH, Diegenbach PC, Delemarre JF, Brekelmans EC, Nieuwlaat JE. Discrimination of hyperplasia and carcinoma of the endometrium by quantitative microscopy-A feasibility study. Histopathology 1981;5:61-8.
21. Pradhan M, Abeler VM, Danielsen HE, Trope CG, Risberg BA. Image cytometryDNAploidy correlates with histological subtypes in endometrial carcinomas. Mod Pathol 2006;19:1227-35.
22. Schulerud H, Kristensen GB, Liestol K, Vlatkovic L, Reith A, Albregtsen F, et al. A review of caveats in statistical nuclear image analysis. Anal Cell Pathol 1998;16:63-82.
23. Arlot S, Celisse A. A survey of cross-validation procedures for model selection. 2010:40-79. Available from: "http://www.di.ens.fr/willow/pdfs/2010-Arlot-Celisse-SS.pdf."
24. Nofech-Mozes S, Ismiil N, Dube V, Saad RS, Ghorab Z, Grin A, et al. Interobserver agreement for endometrial cancer characteristics evaluated on biopsy material. Obstet Gynecol Int 2012;2012:414086.
25. Baak JP, Snijders W, van Diermen B, van Diest PJ, Diepenhorst FW, Benraadt J. Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in international Federation of gynecology and obstetrics stage 1 and 2 endometrial carcinoma. J Clin Oncol 2003;21:4214-21.
26. Pradhan M, Abeler VM, Danielsen HE, Sandstad B, Trope CG, Kristensen GB, et al. Prognostic importance of DNA ploidy and DNA index in stage I and II endometrioid adenocarcinoma of the endometrium. Ann Oncol 2012;23:1178-84.
27. Isaksson A, Wallman M, Göransson H, Gustafsson MG. Cross-validation and bootstrapping are unreliable in small sample classification. Pattern Recogn Lett 2008;29:1960-5.